| Revenue growth | Total income grew 23.6% YoY to ₹923.2 crore. |
|---|---|
| Margins | Operating EBITDA margin expanded to 19.9% in Q4. |
| Order book | Premium under management hit milestone of ₹25,923 crore. |
| Demand visibility | Strong domestic and international demand for AI-driven healthcare administration. |
| Management confidence | Confident, emphasizing high-growth AI platforms and successful M&A integration. |
Growth
Operating income grew 25.1% YoY; technology SaaS revenues surged 91.9% via AI fraud detection and automated claims.
Outlook
Targets tech-led yields 1.5-2x higher than traditional TPA; Paramount integration completion expected by Q2 FY27.
Risks
Retail segment retention dipped slightly; integration of Paramount TPA still requires another 1-2 quarters for full synergies.
Earnings Call filed with NSE, NSE: MEDIASSIST. Summary written with AI assistance from the document.
Medi Assist Healthcare Services Ltd: key numbers
- Share price
- ₹278.60
- Market cap
- ₹2,081 Cr
- Revenue (annual)
- ₹904.8 Cr
- Net profit (annual)
- ₹87.89 Cr
- P/E (TTM)
- 19.5×Sector 54.5×
- Promoter holding
- 4.61%+0.00% QoQ
- FII holding
- 24.55%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Medi Assist Healthcare Services Ltd
All →Medi Assist Healthcare Services Management Change
Medi Assist designated Ms. Aruna Vaidyanathan, Chief Growth & Culture Officer, as Senior Management Personnel effective 4 November 2026. The filing gives her background from TCS and The Economic Times.
Medi Assist Healthcare Services Earnings Call Transcript: Key Takeaways
Medi Assist reported strong H1 FY27 growth while successfully completing Paramount integration, resulting in margin recovery.
Medi Assist Healthcare Services Results Update
Medi Assist reported H1 FY27 results with higher revenue, EBITDA and profit year-on-year. It also announced a board-approved share buyback.
Medi Assist Healthcare Services Investor Presentation: Key Takeaways
Q2FY27 operating revenue ₹241.5 Cr (+3.9%), EBITDA ₹49.2 Cr (+23.9%), margin 20.4% (+331 bps). H1 revenue ₹478.0 Cr (+13.0%); Paramount integration complete.
Medi Assist Healthcare Services Other Announcement
Medi Assist filed its Reg 32 statement for the quarter ended September 30, 2026, reporting no deviation in use of preferential issue proceeds. CARE Ratings' monitoring agency report is enclosed.
Medi Assist Healthcare Services Capital Structure Change
Medi Assist Healthcare's board approved a tender-offer buyback of up to 11,59,199 shares at Rs 425 each, capped at Rs 49.27 Crore. The record date is 20 November 2026, and promoters will not participate.
- Value
- ₹49.27 Cr